비스포스포네이트 관련 악골 골괴사: 문헌고찰

키워드

참고문헌 (52)

1. Advisory Task Force on Bisphosphonate-Related Osteno-necrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
2. Kharazmi M, "Bisphos-phonate-associated osteonecrosis of the auditory canal", Br J Oral Maxillofac Surg, 51, pp.e285~e287 (2013)
3. Tsurushima H, "Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats", Int J Oral Maxillofac Surg, 42, pp.1481~1487 (2013)
4. Mast G, "Incidence of maxillary sinusitis and oro-antral šstulae in bisphosphonate-related osteonecrosis of the jaw", J Craniomaxillofac Surg, 40, pp.568~571 (2012)
5. Bittner T, "American Association of Oral and Maxillofacial Surgeons: Hemimandibulectomy after bisphosphonate treatment for complex regional pain syndrome: a case report and review on the prevention and treatment of bisphosphonate-related osteonecrosis of the jaw", Oral Surg Oral Med Oral Pathol Oral Radiol, 113, pp.41~47 (2012)
6. Kos M, "Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk", J Craniomaxillofac Surg, 38, pp.255~259 (2010)
7. McLeod NM, "Management of patients at risk of bisphosphonate osteonecrosis in maxillofacial surgery units in the UK", Surgeon, 7, pp.18~23 (2009)
8. Lu SY, "Retrospective analysis of 27 cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or nonsurgically", J Dent Sci (2013)
9. Ezra A, "Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption", Adv Drug Deliv Rev, 42, pp.175~195 (2000)
10. Coleman RE, "Risks and benefits of bisphosphonates", Br J Cancer, 98, pp.1736~1740 (2008)
11. Hellstein JW, "Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?", J Oral Maxillofac Surg, 63, pp.682~689 (2005)
12. Kwon TG, "Comparison of chronic osteomyelitis versus bisphosphonate-related osteonecrosis of the jaws in female patients without malignant bone disease", J Oral Maxillofac Surg Med Pathol, 25, pp.214~220 (2013)
13. Russell RG, "Bisphosphonates: pharmacology, mechanisms of action and clinical uses", Osteoporos Int, 9, pp.S66~S80 (1999)
14. Shimizu E, "Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB", J Dent Res, 91, pp.268~274 (2012)
15. Favia G, "Histologic and histomor-phometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy", Bone, 45, pp.406~413 (2009)
16. Scavelli C, "Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma", Mol Cancer Ther, 6, pp.3256~3262 (2007)
17. Marx RE, "Bisphosphonate-induced exposed bone (osteonecrosis", osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, 2005, pp.63, 1567~1575
18. Lerman MA, "Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes", Oral Oncol, 49, pp.977~983 (2013)
19. Ristow O, "Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?", J Oral Maxillofac Surg (2013)
20. McLeod NM, "Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review", Surgeon, 10, pp.36~42 (2012)
21. Reid IR, "Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?", Bone, 41, pp.318~320 (2007)
22. Otto S, "Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment", J Craniomaxillofac Surg, 40, pp.303~309 (2012)
23. Wang J, "Dose-dependent differential effects of risedronate on gene expression in osteoblasts", Biochem Pharmacol, 81, pp.1036~1042 (2011)
24. Otto S, "Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?", J Oral Maxillofac Surg, 68, pp.1158~1161 (2010)
25. Otto S, "Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism", J Oral Maxillofac Surg, 68, pp.2837~2845 (2010)
26. Polidoro S, "Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw", Mutat Res, 757, pp.104~113 (2013)
27. Patel V, "Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention", Br J Oral Maxillofac Surg, 49, pp.251~257 (2011)
28. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update", J Oral Maxillofac Surg, 67(5 Suppl), pp.2~12 (2009)
29. Ficarra G, "Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist", Clin Cases Miner Bone Metab, 4, pp.53~57 (2007)
30. Sarasquete ME, "Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis", Blood, 112, pp.2709~2712 (2008)
31. Lesclous P, "Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?", Bone, 45, pp.843~852 (2009)
32. Bagan JV, "Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases", Oral Oncol, 48, pp.753~757 (2012)
33. Gander T, "Malignancy mimicking bisphosphonate-associated osteo-necrosis of the jaw: a case series and literature review", Oral Surg Oral Med Oral Pathol Oral Radiol, 117, pp.32~36 (2014)
34. Maurer P, "Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris", Int J Oral Maxillofac Surg, 40, pp.285~291 (2011)
35. Otto S, "Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study", J Craniomaxillofac Surg, 39, pp.272~277 (2011)
36. Bianchi SD, "Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, pp.249~258 (2007)
37. Ogura M, "Surgical intervention of osteonecrosis of the jaws associated with bisphosphonate therapy: report of two cases", Asian J Oral Maxillofac Surg, 22, pp.148~153 (2010)
38. McLeod NM, "Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw", Br J Oral Maxillofac Surg, 49, pp.335~342 (2011)
39. Carlson ER, "The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5 Suppl), pp.85~95 (2009)
40. Pichardo SE, "Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?", Oral Surg Oral Med Oral Pathol Oral Radiol, 116, pp.287~292 (2013)
41. Ferlito S, "Treatment of bisphos-phonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases", Br J Oral Maxillofac Surg, 50, pp.425~429 (2012)
42. Assaf AT, "Intraoperative effciency of fluorescence imaging by visually enhanced lesion scope (VELscope®) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ)", J Craniomaxillofac Surg (2013)
43. Khan AA, "Canadian Association of Oral and Maxillofacial Surgeons: Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw", J Rheumatol, 35, pp.1391~1397 (2008)
44. Gallego L, "Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws", Br J Oral Maxillofac Surg, 47, pp.67~68 (2009)
45. Curi MM, "Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphos-phonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases", J Oral Maxillofac Surg, 65, pp.349~355 (2007)
46. Mozzati M, "Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases", Oral Oncol, 48, pp.469~474 (2012)
47. Freiberger JJ, "Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5 Suppl), pp.96~106 (2009)
48. "J Oral Maxillofac Surg", 2007, 573~580
49. Song KE, "A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment", Curr Ther Res, 69, pp.356~362 (2008)
50. Dayisoylu EH, "The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study", Int J Oral Maxillofac Surg, 117, pp.329~334 (2014)
51. Hamada H, "A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography", J Craniomaxillofac Surg (2014)
52. Dayisoylu EH, "Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats", Oral Surg Oral Med Oral Pathol Oral Radiol, 117, pp.329~334 (2014)

관련 논문AI추천